Antimicrobial Medications: Mechanisms, Selection, and Resistance

Antimicrobial Medications

Historical Background of Antibiotics

Antibiotics are substances produced by microorganisms that inhibit or kill other microbes. The discovery and development of antibiotics revolutionized medicine, enabling effective treatment of bacterial infections.

• Paul Ehrlich: Developed the concept of the "magic bullet" and discovered Salvarsan, the first chemotherapeutic agent for syphilis.

• Alexander Fleming: Discovered Penicillin in 1928, the first true antibiotic, produced by the mold Penicillium notatum.

Types of microbes involved in antibiotic production:

• Bacteria (e.g., Streptomyces species)

• Fungi (e.g., Penicillium species)

Features of Antimicrobial Drugs

When selecting an antimicrobial drug, several features must be considered to ensure efficacy and safety.

• Selective toxicity: The drug should harm the microbe but not the host.

• Antimicrobial action: Drugs can be bacteriostatic (inhibit growth) or bactericidal (kill bacteria).

• Spectrum of activity: Broad-spectrum drugs affect a wide range of microbes; narrow-spectrum drugs target specific types.

• Adverse effects: Includes allergic reactions, toxicity, and disruption of normal microbiota.

• Resistance: The ability of microbes to withstand the effects of the drug.

Modes of Action of Antimicrobial Medications

Antimicrobial drugs target specific structures or processes in microbes. The main targets include:

• Cell wall synthesis

• Protein synthesis

• Plasma membrane integrity

• Nucleic acid synthesis

• Biosynthetic pathways

Inhibitors of Cell Wall Synthesis

These drugs prevent the formation of peptidoglycan, essential for bacterial cell wall strength.

• Penicillins: Block transpeptidation in peptidoglycan synthesis.

• Natural penicillins: e.g., Penicillin G (effective against Gram-positive bacteria).

• Semi-synthetic penicillins: e.g., Amoxicillin, Oxacillin (modified for broader spectrum or resistance to β-lactamase).

Purpose of semi-synthetic penicillins: To overcome resistance and expand spectrum.

β-lactam ring: A four-membered ring structure essential for activity; targeted by bacterial enzymes (β-lactamases) that confer resistance.

Resistance development: Bacteria produce β-lactamase enzymes that break the β-lactam ring, rendering the drug ineffective.

Inhibitors of Protein Synthesis

These drugs target bacterial ribosomes (70S), which differ from eukaryotic ribosomes (80S), allowing selective toxicity.

• Aminoglycosides: e.g., Streptomycin (binds 30S subunit, causes misreading of mRNA).

• Tetracyclines: Block attachment of tRNA to the ribosome.

• Macrolides: e.g., Erythromycin (binds 50S subunit, inhibits peptide chain elongation).

Antibiotics Affecting Plasma Membrane, Nucleic Acid Synthesis, and Biosynthetic Pathways

• Plasma membrane: Polymyxins disrupt membrane integrity, causing cell lysis.

• Nucleic acid synthesis: Quinolones (e.g., Ciprofloxacin) inhibit DNA gyrase; Rifamycins inhibit RNA polymerase.

• Biosynthetic pathways: Sulfonamides inhibit folic acid synthesis, essential for nucleotide production.

Resistance to Antimicrobial Drugs

Bacterial resistance to antibiotics is a major clinical concern. Resistance can arise through various mechanisms and is often accelerated by misuse of antibiotics.

Mechanisms of Resistance

Bacteria can become resistant to antibiotics through:

1. Enzymatic destruction or inactivation: e.g., β-lactamase breaks down β-lactam antibiotics.

2. Alteration of target site: Mutations change the drug's binding site, reducing efficacy.

3. Decreased uptake: Changes in membrane permeability prevent drug entry.

4. Efflux pumps: Bacteria actively expel the drug from the cell.

Selective advantage: Resistant bacteria survive and multiply in the presence of antibiotics, leading to the spread of resistance.

Link between misuse and resistance: Overuse and inappropriate use of antibiotics (e.g., for viral infections) increase selective pressure, promoting resistance.

Summary Table: Main Classes of Antimicrobial Drugs

Drug Class	Main Target	Example	Mechanism
Penicillins	Cell wall synthesis	Penicillin G, Amoxicillin	Inhibit transpeptidation; β-lactam ring
Aminoglycosides	Protein synthesis	Streptomycin	Bind 30S ribosomal subunit
Tetracyclines	Protein synthesis	Tetracycline	Block tRNA attachment
Macrolides	Protein synthesis	Erythromycin	Bind 50S ribosomal subunit
Polymyxins	Plasma membrane	Polymyxin B	Disrupt membrane integrity
Quinolones	Nucleic acid synthesis	Ciprofloxacin	Inhibit DNA gyrase
Sulfonamides	Biosynthetic pathways	Sulfamethoxazole	Inhibit folic acid synthesis

Key Equations and Concepts

• Minimum Inhibitory Concentration (MIC): The lowest concentration of an antimicrobial that prevents visible growth of a microorganism.

$\text{MIC} = \text{Lowest concentration with no visible growth}$

• Therapeutic Index: Ratio of toxic dose to effective dose.

$\text{Therapeutic Index} = \frac{\text{Toxic Dose}}{\text{Therapeutic Dose}}$

Example: Antibiotic Resistance in Clinical Practice

When a patient is treated with antibiotics, bacteria with resistance genes survive and multiply. If antibiotics are overused, resistant strains become dominant, making infections harder to treat.

Additional info: The study guide references figures (20.2, 20.4) which likely illustrate drug mechanisms and resistance pathways. The above notes expand on these concepts for clarity and completeness.